These results indicate that the activation of STAT3 was important for the transcriptional activity of NFKBIZ in the psoriatic signaling pathway via IL-17A or IL-22 and SKSI-0412 could function as a key regulator of IκBζ in the treatment of psoriasis. The gene discussed is IL22; the disease is psoriasis.